KPV

Product overview

KPV (Lysine–Proline–Valine) is a regulatory tripeptide of synthetic origin, studied in research settings for its role in inflammatory modulation processes, intracellular signaling, and structure–function dynamics in controlled biological systems.

Derived from the C-terminal sequence of α-melanocyte stimulating hormone (α-MSH), KPV retains the regulatory properties associated with the parent molecule, while presenting a minimal structure, high chemical stability, and absence of melanocortin receptor activity.

This 10 mg lyophilized preparation is designed to support reproducible laboratory studies focused on the mechanistic evaluation of cellular pathways and on the comparative modeling of regulatory peptide behavior.

Peptide overview

Scientific interest in KPV developed starting in the 1990s, when research began to identify short bioactive peptide fragments as autonomous functional units capable of modulating specific biochemical pathways without activating complex endocrine systems.

Between 1995 and 2015, KPV was widely used as an experimental model to:

study intracellular inflammatory signaling

analyze the role of tripeptides in immune regulation

evaluate the behavior of sequences derived from longer neuropeptides

From 2015 to 2025, the use of KPV became consolidated in in vitro and preclinical studies focused on the selective modulation of cellular response pathways, with particular attention to peptide transport mechanisms, regulated intracellular communication, and structure–activity relationships.

Historical and scientific context

Early studies on KPV helped demonstrate that the biological activity of α-MSH could be traced back to an extremely short peptide sequence, paving the way for the study of functional minimal peptides.

Throughout the 2000s, KPV was employed as a reference molecule to explore:

inhibition of major intracellular pro-inflammatory pathways

the role of di- and tripeptide transporters (such as PepT1) in cellular distribution

the distinction between surface receptor–mediated signaling and direct intracellular mechanisms

Between 2020 and 2025, KPV continued to be used as a reproducible structural model for the analysis of:

regulated signaling cascades

peptide–cellular environment interactions

comparative behavior of regulatory peptides under standardized experimental conditions

Research focus on mechanisms

Experimental studies on KPV primarily focus on:

Modulation of intracellular inflammatory pathways, including NF-κB and MAP kinase cascades

PepT1-mediated peptide transport and selective uptake in epithelial and immune cells

Structure–function analysis of bioactive tripeptides in controlled in vitro systems

Peptide–signaling interactions independent of melanocortin receptors

Comparative modeling of regulatory peptide behavior relative to longer sequences

These aspects make KPV a particularly useful research tool for the study of fine cellular regulation, without hormonal interference or non-specific systemic activation.